The link between resolving inflammation and fibrosis is an artefact of culture plastic

Macrophage

An immune cell that takes up cells and debris and releases signals that affect surrounding tissue. Its cleanup and signaling activities are the two functions being compared here.

Inflammation resolution and specialized pro-resolving mediators (SPMs)

Resolution is the process through which inflammation subsides. Specialized pro-resolving mediators are a class of signaling molecules associated with that process; the question asks whether their effects on cleanup also change a scar-promoting signal.

M1, M2, polarization, and differentiation

M1 and M2 are conventional labels for broadly inflammation-associated and repair-associated macrophage states. Polarization and differentiation describe shifts in cell characteristics; these labels summarize varied states rather than two fixed types, and M2 does not itself mean scar-free repair.

Stem cell niche

The local cells, signals, and physical surroundings that support stem cells, which can produce replacement cells. The question concerns macrophages in that environment, but the supplied input does not identify a particular human tissue niche.

Transforming growth factor beta 1 (TGF-β1) and TGFB1

TGF-β1 is a signaling protein described here in both inflammation-reducing and scar-promoting roles. TGFB1 names the gene encoding it; a change in gene expression does not by itself establish a change in protein release.

Gene expression and protein secretion

Gene expression is the use of genetic instructions to produce a cell's products. Secretion is release of a substance from the cell; the question asks about secretion, while S2 and S4 report expression of the gene encoding the protein.

Fibroblast, fibroblast activation, fibrosis, and collagen

Fibroblasts are cells that produce material supporting tissue, including the structural protein collagen. Activation can increase this activity, while fibrosis means excessive buildup of scar-like material; collagen uptake is removal into cells, not a direct measurement of scar formation.

Senescent cells and aged red blood cells

In the proposed niche problem, senescent cells are cells in a lasting state of no longer dividing. S7 concerns aged red blood cells, which carry oxygen; the supplied material does not establish that clearing them represents clearance of the senescent cells intended by the gap.

Efferocytosis

The process by which cells such as macrophages take up and clear dying cells. The sources use it for cleanup outcomes, which must be distinguished from measurements of released signaling proteins.

Acomys

The genus of African spiny mice named in the question. The proposed mechanism in these animals and its claimed absence in humans are premises under audit, not findings established by the supplied sources.

Interferon regulatory factor 4 (IRF4) and half-site

IRF4 is a protein that regulates gene activity by participating in binding to genetic material. A half-site is part of a larger binding pattern; the input proposes a mechanism involving such a site but supplies no establishing evidence.

CpG methylation

CpG denotes a cytosine followed by a guanine in deoxyribonucleic acid, the material carrying genetic instructions; the letter p represents the connecting phosphate. Methylation is addition of a chemical mark at such a site, proposed here to alter the relationship between inflammation resolution and scarring.

Co-binding

Binding involving more than one participant at a site or target. The gap description uses this term for IRF4 and TGF-β1 without specifying the participants' roles or binding target, so its precise meaning is not established here.

Human monocyte-derived macrophages

Macrophages developed from human monocytes, a type of blood immune cell. Findings in these cells do not by themselves establish the same response in macrophages within a stem cell niche.

Corneal fibroblasts, ultraviolet B, and physical separation

Corneal fibroblasts are support-producing cells from the eye's clear front surface. S2 uses ultraviolet B light to injure these cells and a compartment-separated laboratory setup involving macrophages; this is a different setting from the human niche specified in the question.

Itaconate

A molecule produced through cellular chemical processing. S4 links its late production to resolution-associated macrophage changes, but does not test the specialized pro-resolving mediator intervention asked about.

Matrix metalloproteinase 8

An enzyme involved in breaking down material surrounding cells. S4 reports its reduction alongside other changes, without establishing the requested TGF-β1 secretion outcome.

17R-resolvin D2

The particular resolution-promoting signaling molecule studied in S7. Its reported effects on macrophage state and cell clearance provide nearby evidence, but not the requested measurement of TGF-β1 release.

Glutamine metabolism

The chemical processing of glutamine, a molecule cells use as a nutrient and building material. S5 connects that processing to M2 polarization without establishing the secretion response in the question.

Acomys IRF4-half-site CpG methylation decouples pro-resolution from fibrosis, and this decoupling mechanism is absent in humans.

The assumption concerns African spiny mice, a proposed short genetic binding site for a protein that regulates gene activity, and a chemical mark at that site. It claims that the mark lets inflammation subside without triggering scarring in these mice, while humans lack that separation. If established, this would supply a species-specific reason to question whether repair signals have the same scarring consequences in humans.

The supplied search results do not return work establishing either the proposed mouse mechanism or its absence in humans. S2 and S4 report changes in gene expression in other settings, S7 reports repair-associated and clearance effects of a resolution signal, and S5 and S9 concern other aspects of macrophage activity. None establishes the asserted species difference; this bounded set of sources does not show that the premise is false.S2S4S5S7S9

The same question asked without the part nothing read establishes:

• Does treatment with specialized pro-resolving mediators increase or decrease TGF-β1 release as macrophages in the human stem cell niche adopt an M2 repair-associated state?
• In macrophages in the human stem cell niche, does treatment with specialized pro-resolving mediators support debris clearance without increasing TGF-β1 release or fibroblast activation?

• TGF-β1 release increases Under the question's proposed mechanism, a treatment that promotes debris clearance would also increase a signal capable of activating fibroblasts. Clearance and scar-promoting activity could therefore rise together, so the repair-associated cell state would not by itself establish the desired separation.
• TGF-β1 release decreases If debris clearance also improved, the treatment would combine greater removal of unwanted material with less release of this scar-promoting signal. That would fit the requested separation at the level of these two measurements, but would not by itself establish reduced tissue scarring.
• No consistent direction If release remained unchanged or differed across conditions, the M2 label would not identify a consistent change in this signal. Any improvement in clearance would then leave the proposed effect on fibroblast activation unresolved.

The proposed chain starts with a signal changing the activity of tissue-cleaning immune cells. Those cells would need to remove debris while avoiding release of enough scar-promoting signals to activate fibroblasts. If the same treatment increased TGF-β1 release, interpreting a repair-associated cell state as evidence of scar-free repair could be mistaken. If it decreased release, assuming that repair-associated activity necessarily increases this scarring signal could also be mistaken. Neither direction alone would establish restoration of the environment that supports stem cells.